**Core Concept:** Chronic Kidney Disease (CKD) is a long-term decline in kidney function, leading to accumulation of waste products and fluid imbalances. Hypertension is a common complication in CKD patients, requiring appropriate treatment to prevent cardiovascular complications and slow disease progression.

**Why the Correct Answer is Right:**

The correct answer is **D** - ACE inhibitors (Angiotensin-Converting Enzyme inhibitors) as they are the initial treatment of choice for hypertension in CKD patients. ACE inhibitors work by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor and aldosterone stimulator. As a result, ACE inhibitors help:

1. Reduce blood pressure by blocking the renin-angiotensin-aldosterone system (RAAS) activation.
2. Improve renal function by reducing vasoconstriction and inflammation.
3. Lessen proteinuria, which may slow the progression of kidney disease.

**Why Each Wrong Option Is Incorrect:**

Option A - Calcium channel blockers (CCBs) are not the first-line choice because they have limited renoprotective effects and may worsen renal function in CKD patients.

Option B - Diuretics (e.g., loop diuretics) are helpful in reducing fluid volume but may not address the underlying RAAS activation, leading to inadequate blood pressure control.

Option C - Angiotensin II receptor blockers (ARBs) are a second-line choice after ACE inhibitors due to their similar mechanism and potential for worsening renal function in CKD patients.

**Clinical Pearl:**

In CKD patients with hypertension, ACE inhibitors are the preferred initial treatment option due to their renoprotective effects and better blood pressure control. If ACE inhibitors are contraindicated or ineffective, switching to ARBs or considering alternative antihypertensive options such as CCBs or diuretics may be considered, but these should be used cautiously in CKD patients.